The ADHD Landscape – Why are all stimulants not the same (Clinical lunch chat held on 14 April 2026)

CPD-Banner---The-ADHD-Landscape

In this Clinical Lunch Chats episode, Dr Rust Theron is joined by a Psychiatrist, Professor Renata
Schoeman to explore the current ADHD treatment landscape, with a particular focus on why
stimulant medications differ and how these differences impact clinical decision-making in primary
care.

Learning Outcomes

You will learn how to:

  • Describe the current understanding of ADHD across the lifespan, including its clinical presentation in children and adults.
  • Differentiate between stimulant medication classes and formulations, including short-acting and long-acting preparations.
  • Explain how pharmacokinetic differences influence clinical outcomes, including onset, duration, and adherence.
  • Identify patient-specific factors that guide stimulant selection, including comorbidities and lifestyle considerations.
  • Apply practical approaches to initiating, titrating, and monitoring stimulant therapy in
    primary care.

To access this module, please register or login: